Artelo Biosciences, Inc. (ARTL) Financials
ARTL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-08-31 | 15.5 million | 921000 |
| 2023-05-31 | 16.9 million | 609000 |
| 2023-02-28 | 20.4 million | 1.0 million |
| 2022-11-30 | 20.4 million | 1.0 million |
ARTL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-08-31 | -1.8 million | 222000 |
| 2023-05-31 | -1.6 million | 225000 |
| 2023-02-28 | -2.3 million | 608000 |
| 2022-11-30 | -2.3 million | 608000 |
ARTL Net Income
No data available :(
ARTL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-08-31 | 12.9 million | - | 32000 |
| 2023-05-31 | 14.0 million | - | 40000 |
| 2023-02-28 | 17.5 million | - | 52000 |
| 2022-11-30 | - | - | 63000 |
ARTL Shares Outstanding
ARTL Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-08-31 | - | 1.6 million | 1.0 million | - |
| 2023-05-31 | - | 752000 | 1.0 million | - |
| 2023-02-28 | - | 1.7 million | 1.8 million | - |
| 2022-11-30 | - | 1.7 million | 1.8 million | - |
ARTL Cost of Revenue
No data available :(
ARTL
Price: $1.33
52 week price:
Earnings Per Share: -3.14 USD
P/E Ratio: -0.41
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 36149
Market Capitalization: 4.4 million